206 related articles for article (PubMed ID: 21747585)
1. Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.
Kumari R; Lakhan R; Garg RK; Kalita J; Misra UK; Mittal B
Indian J Hum Genet; 2011 May; 17 Suppl 1(Suppl 1):S32-40. PubMed ID: 21747585
[TBL] [Abstract][Full Text] [Related]
2. Association of alpha subunit of GABAA receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population.
Kumari R; Lakhan R; Kalita J; Misra UK; Mittal B
Seizure; 2010 May; 19(4):237-41. PubMed ID: 20356767
[TBL] [Abstract][Full Text] [Related]
3. Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy.
Lakhan R; Kumari R; Singh K; Kalita J; Misra UK; Mittal B
Indian J Med Res; 2011 Sep; 134(3):295-301. PubMed ID: 21985811
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
[TBL] [Abstract][Full Text] [Related]
5. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
[TBL] [Abstract][Full Text] [Related]
6. ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: A case-control study.
Mousavi SF; Hasanpour K; Nazarzadeh M; Adli A; Bazghandi MS; Asadi A; Rad A; Gholami O
Seizure; 2022 Apr; 97():58-62. PubMed ID: 35338956
[TBL] [Abstract][Full Text] [Related]
7. The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children.
Abo El Fotoh WM; Abd El Naby SA; Habib MS; ALrefai AA; Kasemy ZA
Seizure; 2016 Oct; 41():75-80. PubMed ID: 27498208
[TBL] [Abstract][Full Text] [Related]
8. Association between Genetic Polymorphism of
Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
[No Abstract] [Full Text] [Related]
9. Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.
Lakhan R; Kumari R; Misra UK; Kalita J; Pradhan S; Mittal B
Br J Clin Pharmacol; 2009 Aug; 68(2):214-20. PubMed ID: 19694741
[TBL] [Abstract][Full Text] [Related]
10. Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population.
Vahab SA; Sen S; Ravindran N; Mony S; Mathew A; Vijayan N; Nayak G; Bhaskaranand N; Banerjee M; Satyamoorthy K
Drug Metab Pharmacokinet; 2009; 24(3):255-60. PubMed ID: 19571437
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
[TBL] [Abstract][Full Text] [Related]
12. Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy.
Afsar NA; Haenisch S; Mateen A; Usman A; Ufer M; Ahmed KZ; Ahmad HR; Cascorbi I
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):570-6. PubMed ID: 20102361
[TBL] [Abstract][Full Text] [Related]
13. An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children.
Makowska M; Smolarz B; Bryś M; Forma E; Romanowicz H
Int J Neurosci; 2021 Dec; 131(12):1147-1154. PubMed ID: 32567426
[TBL] [Abstract][Full Text] [Related]
14. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
Kousar S; Wafai ZA; Wani MA; Jan TR; Andrabi KI
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):504-16. PubMed ID: 25943175
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
[TBL] [Abstract][Full Text] [Related]
17. Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients.
Maleki M; Sayyah M; Kamgarpour F; Karimipoor M; Arab A; Rajabi A; Gharagozli K; Shamshiri AR; Shahsavand Ananloo E
Iran Biomed J; 2010 Jul; 14(3):89-96. PubMed ID: 21079659
[TBL] [Abstract][Full Text] [Related]
18. Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus.
Berseem NF; Khattab ESAEH; Saad DS; Abd Elnaby SA
CNS Neurol Disord Drug Targets; 2022; 21(5):450-457. PubMed ID: 34607551
[TBL] [Abstract][Full Text] [Related]
19.
Pontual Y; Pacheco VSS; Monteiro SP; Quintana MSB; Costa MJM; Rolla VC; de Castro L
Clin Sci (Lond); 2017 Aug; 131(15):1831-1840. PubMed ID: 28572401
[TBL] [Abstract][Full Text] [Related]
20. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
